Evaluation of Pharmacokinetics of Paroxetine Following Single and Repeat Oral Administration of Mesafem (7.5 mg Paroxetine Mesylate) Capsules in Healthy Postmenopausal Women
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Paroxetine (Primary)
- Indications Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors Noven Therapeutics
- 19 Apr 2013 New trial record